£325.00

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia

Price data last checked 85 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 6 days • 6 data points (No recent data available)

Historical
Generating forecast...
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 26 January 2026 27 January 2026 28 January 2026 29 January 2026 31 January 2026

Price Distribution

Price distribution over 6 days • 1 price levels

Days at Price
6 days 0 2 3 5 6 £325 Days at Price

Price Analysis

Most common price: £325 (6 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 6 days

Product Specifications
Format
paperback
ASIN
B00E4DVLPM
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 31 Mar 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 25 Mar 2026
The 2013-2018 Outlook for Melanoma Therapeutics in India
96% match

The 2013-2018 Outlook for Melanoma Therapeutics in India

£495.00 14 Feb 2026
The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa
96% match

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa

£325.00 06 Feb 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
96% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana

£325.00 28 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean

£325.00 28 Jan 2026
The 2016-2021 Outlook for Cancer Therapies in Asia
95% match

The 2016-2021 Outlook for Cancer Therapies in Asia

£425.00 24 Jan 2026
The 2013-2018 Outlook for Clinical Chemistry Analyzers and Reagents in Asia
95% match

The 2013-2018 Outlook for Clinical Chemistry Analyzers and Reagents in Asia

£325.00 13 Jan 2026
The 2013-2018 Outlook for Lymphoma Therapeutics in Africa
95% match

The 2013-2018 Outlook for Lymphoma Therapeutics in Africa

£325.00 07 Feb 2026
The 2013-2018 Outlook for Astaxanthin in Asia
95% match

The 2013-2018 Outlook for Astaxanthin in Asia

£325.00 31 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe

£325.00 24 Jan 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
95% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 13 Dec 2025
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
95% match

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

£325.00 08 Feb 2026
The 2013-2018 Outlook for Phytosterols in Asia
95% match

The 2013-2018 Outlook for Phytosterols in Asia

£325.00 25 Jan 2026
The 2023-2028 World Outlook for Non-Small Cell Lung Cancers
95% match

The 2023-2028 World Outlook for Non-Small Cell Lung Cancers

Out of Stock 23 Jan 2026
The 2013-2018 Outlook for Anticoagulants in Asia
95% match

The 2013-2018 Outlook for Anticoagulants in Asia

£325.00 24 Jan 2026
The 2013-2018 Outlook for Cell Culture Media in Asia
95% match

The 2013-2018 Outlook for Cell Culture Media in Asia

£325.00 13 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East

£325.00 24 Jan 2026
The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in Asia
95% match

The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in Asia

£325.00 11 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America

£325.00 29 Jan 2026
The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India
95% match

The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India

£495.00 13 Jan 2026
The 2013-2018 Outlook for Ion Exchange Resins in Asia
95% match

The 2013-2018 Outlook for Ion Exchange Resins in Asia

£325.00 11 Jan 2026
The 2013-2018 Outlook for Medical Oxygen Systems in Asia
95% match

The 2013-2018 Outlook for Medical Oxygen Systems in Asia

£325.00 15 Apr 2026
The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States
95% match

The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States

£495.00 23 Jan 2026